Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 27.14% vs 48.25% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is -6.03% vs 16.78% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is -14.29% vs 84.02% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025
Compare Quarterly Results Of Suzhou Highfine Biotech Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is 2.57% vs 1.95% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 27.14% vs 48.25% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 181.90% vs -50.43% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -6.03% vs 16.78% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is -16.62% vs 25.68% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -14.29% vs 84.02% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is 0.00% vs -60.00% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025






